Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 09 2019
Historique:
received: 10 10 2018
accepted: 30 08 2019
entrez: 22 9 2019
pubmed: 22 9 2019
medline: 7 1 2020
Statut: epublish

Résumé

Supplementation with the NAD

Identifiants

pubmed: 31541116
doi: 10.1038/s41467-019-12262-x
pii: 10.1038/s41467-019-12262-x
pmc: PMC6754455
doi:

Substances chimiques

Blood Glucose 0
Protective Agents 0
Pyridinium Compounds 0
nicotinamide-beta-riboside 0I8H2M0L7N
NAD 0U46U6E8UK
Niacinamide 25X51I8RD4
Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.-
Nmrk1 protein, mouse EC 2.7.1.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4291

Références

Cell Metab. 2016 Aug 9;24(2):269-82
pubmed: 27508874
Sci Rep. 2016 May 27;6:26933
pubmed: 27230286
Mol Nutr Food Res. 2017 Aug;61(8):
pubmed: 28211258
Cell Metab. 2007 Oct;6(4):307-19
pubmed: 17908559
Metabolism. 1988 Mar;37(3):287-301
pubmed: 3278194
Nature. 2001 Sep 13;413(6852):131-8
pubmed: 11557972
Nature. 2017 Dec 14;552(7684):187-193
pubmed: 29211722
Mol Metab. 2018 May;11:178-188
pubmed: 29551635
Nat Commun. 2016 Oct 11;7:13103
pubmed: 27725675
Cell. 2013 Jul 18;154(2):430-41
pubmed: 23870130
Cell. 2004 May 14;117(4):495-502
pubmed: 15137942
Cell Rep. 2018 Jun 5;23(10):2976-2988
pubmed: 29874584
Cell. 2013 Dec 19;155(7):1624-38
pubmed: 24360282
Cell Metab. 2011 Oct 5;14(4):528-36
pubmed: 21982712
PLoS One. 2012;7(7):e42357
pubmed: 22848760
Cell Metab. 2009 Apr;9(4):327-38
pubmed: 19356714
Cell Metab. 2018 Jan 9;27(1):22-41
pubmed: 28867301
Br J Pharmacol. 2016 Aug;173(15):2352-68
pubmed: 27174364
Cell Metab. 2015 Jul 7;22(1):31-53
pubmed: 26118927
Curr Protoc Mouse Biol. 2015 Jun 01;5(2):135-153
pubmed: 26069081
J Appl Physiol (1985). 2017 Apr 1;122(4):1019-1030
pubmed: 28126909
Cell Metab. 2014 Jun 3;19(6):1042-9
pubmed: 24814483
J Mol Biol. 2009 May 15;388(4):730-50
pubmed: 19303024
Cell Metab. 2018 Mar 6;27(3):513-528
pubmed: 29249689
Nat Med. 2015 Aug;21(8):887-94
pubmed: 26168293
Nature. 2001 Sep 13;413(6852):179-83
pubmed: 11557984
J Biol Chem. 2009 Jun 19;284(25):17110-9
pubmed: 19416965
PLoS One. 2011 May 11;6(5):e19710
pubmed: 21589930
Trends Pharmacol Sci. 2017 Jul;38(7):649-665
pubmed: 28551355
PLoS One. 2011 Apr 26;6(4):e19194
pubmed: 21541336
J Hepatol. 2017 Jan;66(1):132-141
pubmed: 27663419
Hepatology. 2016 Apr;63(4):1190-204
pubmed: 26404765
EMBO Mol Med. 2014 Apr 06;6(6):721-31
pubmed: 24711540
Nat Commun. 2016 Oct 12;7:13125
pubmed: 27731316
Hepatology. 2017 Feb;65(2):616-630
pubmed: 27809334
J Hepatol. 2017 Mar;66(3):589-600
pubmed: 27984176
Cell Metab. 2012 Jun 6;15(6):838-47
pubmed: 22682224
Am J Physiol Endocrinol Metab. 2018 Apr 1;314(4):E377-E395
pubmed: 29208611
Cell Rep. 2015 Oct 20;13(3):533-545
pubmed: 26456827
Mol Cell. 2011 Oct 21;44(2):177-90
pubmed: 21856199
Cell Metab. 2016 Oct 11;24(4):566-581
pubmed: 27732836
PLoS One. 2016 Jan 12;11(1):e0147037
pubmed: 26756334
Biochem J. 1987 May 15;244(1):101-8
pubmed: 2444209

Auteurs

Audrey Sambeat (A)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Joanna Ratajczak (J)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.
School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Magali Joffraud (M)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

José L Sanchez-Garcia (JL)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Maria P Giner (MP)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Armand Valsesia (A)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Judith Giroud-Gerbetant (J)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Miriam Valera-Alberni (M)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.
School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Angelique Cercillieux (A)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.
School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.

Marie Boutant (M)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Sameer S Kulkarni (SS)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Sofia Moco (S)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland.

Carles Canto (C)

Nestlé Research, EPFL Innovation Park, 1015, Lausanne, Switzerland. carlos.cantoalvarez@rd.nestle.com.
School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland. carlos.cantoalvarez@rd.nestle.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH